D-0415-2018 Class II Terminated

Recalled by Hetero Labs Limited Unit V — Jadcherla Mandal, Mahaboob Nagar

FDA drug recall D-0415-2018 was initiated by Hetero Labs Limited Unit V on Dec 22, 2017 and is designated Class II. Reason for recall: Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution. The recall status is terminated (terminated Feb 5, 2020). Affected quantity: 8,436 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 21, 2018
Initiation Date
Dec 22, 2017
Termination Date
Feb 5, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,436 bottles

Product description

Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30

Reason for recall

Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.

Distribution pattern

Nationwide in the USA.

Code information

Lot # FMC17039, Exp 07/2019.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0415-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0415-2018. Report a data issue: hello@regdatalab.com.